David Scadden, a director at Agios Pharmaceuticals ($AGIO), sold shares on the open market five times over the past year, totaling nearly $90,000. His most recent sale occurred on November 12, 2025. These transactions rank 9,742nd among 11,678 individual insiders, compared to an average sale value of $8.6 million and about 6.4 transactions per insider. Scadden made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 12, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | S | Common stock | 200 | $43.84 | 17,603.0000 | 74,496,287,000 | 1.12% | 0.00% |
| Nov. 12, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | M | Stock options (right to buy) | 200 | $0.00 | 26,907.0000 | 74,496,287,000 | 0.74% | 0.00% |
| Nov. 12, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | M | Common stock | 200 | $18.09 | 17,803.0000 | 74,496,287,000 | 1.14% | 0.00% |
| Oct. 8, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | M | Common stock | 200 | $18.09 | 17,803.0000 | 74,496,287,000 | 1.14% | 0.00% |
| Oct. 8, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | S | Common stock | 200 | $41.00 | 17,603.0000 | 74,496,287,000 | 1.12% | 0.00% |
| Oct. 8, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | M | Stock options (right to buy) | 200 | $0.00 | 27,107.0000 | 74,496,287,000 | 0.73% | 0.00% |
| Sept. 30, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | M | Stock options (right to buy) | 200 | $0.00 | 27,307.0000 | 74,254,956,000 | 0.73% | 0.00% |
| Sept. 30, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | M | Common stock | 200 | $18.09 | 17,803.0000 | 74,254,956,000 | 1.14% | 0.00% |
| Sept. 30, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | S | Common stock | 200 | $40.00 | 17,603.0000 | 74,254,956,000 | 1.12% | 0.00% |
| Aug. 27, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | S | Common stock | 200 | $40.00 | 17,603.0000 | 74,254,956,000 | 1.12% | 0.00% |
| Aug. 27, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | M | Common stock | 200 | $18.09 | 17,803.0000 | 74,254,956,000 | 1.14% | 0.00% |
| Aug. 27, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | M | Stock options (right to buy) | 200 | $0.00 | 27,507.0000 | 74,254,956,000 | 0.72% | 0.00% |
| July 10, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | S | Common stock | 1400 | $40.00 | 17,603.0000 | 74,254,956,000 | 7.37% | 0.00% |
| July 10, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | M | Common stock | 1400 | $18.09 | 19,003.0000 | 74,254,956,000 | 7.95% | 0.00% |
| July 10, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | M | Stock options (right to buy) | 1400 | $0.00 | 27,707.0000 | 74,254,956,000 | 4.81% | 0.00% |
| June 18, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | A | Stock options (right to buy) | 15768 | $0.00 | 15,768.0000 | 74,103,192,000 | 9999.99% | 0.00% |
| June 20, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | M | Common stock | 2120 | $0.00 | 17,603.0000 | 74,103,192,000 | 13.69% | 0.00% |
| June 18, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | A | Restricted stock units | 2816 | $0.00 | 2,816.0000 | 74,103,192,000 | 9999.99% | 0.00% |
| June 20, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | M | Restricted stock units | 2120 | $0.00 | 0.0000 | 74,103,192,000 | 100.00% | 0.00% |
| June 6, 2025 | Editas Medicine, Inc. | $EDIT | Scadden David | Director | A | Stock Option (right to buy) | 37500 | $0.00 | 37,500.0000 | 82,976,284 | 9999.99% | 0.05% |
| Dec. 11, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | M | Common stock | 200 | $18.09 | 15,683.0000 | 73,237,954,000 | 1.29% | 0.00% |
| Dec. 11, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | M | Stock options (right to buy) | 200 | $0.00 | 29,107.0000 | 73,237,954,000 | 0.68% | 0.00% |
| Dec. 11, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | S | Common stock | 200 | $46.28 | 15,483.0000 | 73,237,954,000 | 1.28% | 0.00% |
| July 1, 2024 | Carisma Therapeutics Inc. | $CARM | Scadden David | Director | A | Stock Option (Right to Buy) | 38700 | $0.00 | 38,700.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | A | Restricted stock units | 2120 | $0.00 | 2,120.0000 | 72,967,922,000 | 9999.99% | 0.00% |
| June 20, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | A | Stock options (right to buy) | 11774 | $0.00 | 11,774.0000 | 72,967,922,000 | 9999.99% | 0.00% |
| June 13, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | M | Restricted stock units | 3388 | $0.00 | 0.0000 | 72,967,922,000 | 100.00% | 0.00% |
| June 13, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | M | Common stock | 3388 | $0.00 | 15,483.0000 | 72,967,922,000 | 28.01% | 0.00% |
| May 30, 2024 | Editas Medicine, Inc. | $EDIT | Scadden David | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| June 21, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | M | Common stock | 4975 | $0.00 | 12,095.0000 | 71,256,118 | 69.87% | 0.01% |
| June 21, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | M | Restricted stock unit | 4975 | $0.00 | 0.0000 | 71,256,118 | 100.00% | 0.01% |
| June 13, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | A | Stock options (right to buy) | 18958 | $0.00 | 18,958.0000 | 71,256,118 | 9999.99% | 0.03% |
| June 13, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Scadden David | Director | A | Restricted stock units | 3388 | $0.00 | 3,388.0000 | 71,256,118 | 9999.99% | 0.00% |
| June 1, 2023 | Editas Medicine, Inc. | $EDIT | Scadden David | Not found | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |